Bose Institute was set up in 1917 by Sir JC Bose, the founder of modern science in the Indian subcontinent. It is Asia's first modern research centre devoted to interdisciplinary research and bears a century old tradition of research excellence. Bose Institute is Asia's first modern research centre devoted to interdisciplinary research. Since inception, the Institute has been visited by numerous stalwarts, such as the writer Aldous Huxley (1926), heads of foreign states like King Albert I of Belgium (1925) and President Brezhnev of USSR (1959).
Govt. of Himachal Pradesh took up initiative in early seventies to set up a CSIR lab to make prudential use of the natural resources of the region. After several levels of discussions a formal request was made by then Chief Minister of HP to Vice President, CSIR in 1982 for initiating the matter, and giving final shape to the proposal. The dream of HP government finally came true in 1983 when the foundation stone of this National lab was laid as CSIR Complex Palampur by Prof. Nurul Hasan, former Vice President of CSIR, with then Chief Minister of HP chairing the function.
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
ABOUT AUTHORS Balasubramanian Sathyamurthy*, Sushmitha.H.S
Department of Biochemistry,
Ramaiah College of Arts, Science and Commerce, Bangalore, Karnataka, India
ABSTRACT:
The key proteins involved in causing dengue are seven major proteins, which are considered as major therapeutic targets for dengue drug development. Recent studies have reported positively for NS1 protein in dysregulation of causing dengue process in humans. Dragon fruit seed phytochemicals are reported to have antioxidant and antiviral properties. In the present study we studied binding efficiency of 11 compounds that are present in the dragon fruit seeds with NS1 Protein through Insilico methods. By our virtual screening and docking result, we found that the Compound A, Compound B and Compound C have highest binding affinity with the NS1 Protein and also we predicted the binding site amino acid residues and the nature of hydrogen bonding. However more invivo experimental validation of our results with animal models will enlighten the development of more potent drugs from these compounds for treatment of dengue.
ABOUT AUTHORS
Nyira Shafi*1, Mohd Akbar Dar1, Mubashir Hussain Masoodi1, Urfan Nabi2 1Department of Pharmaceutical Sciences,
School of Applied Sciences and Technology,
University of Kashmir, Srinagar, J&K, India 2 Department of Pharmacology,
Govt. Medical College Srinagar, J&K, India
ABSTRACT Purpose: To study the adverse drug reactions (ADR’s) reported from Dermatology ward in SMHS hospital of Srinagar. The adverse drug reactions were analyzed by Naranjo’s causality assessment scale and the outcomes were studied.
Methods: This observational and cross-sectional study was conducted for one month of July 2018 in an inpatient setting of Dermatology ward of SMHS hospital. The data collection was done only in Dermatology ward. Patients of all age groups and either sex were included in this study. The adverse drug reactions were assessed for their causality by performing the Naranjo’s algorithm scale. The outcomes were studied.
Jail, which is also known as prison, is a place used for the detention of prisoners. To maintain the administrative arrangement in the Jails of Chhattisgarh, Jail Superintendents are posted in the Central Jails and District Jails. Medical Officers are posted as a Superintendent in Sub Jails.
Hooghly District Unit of National Informatics Centre, Ministry of Communication and Information Technology, Govt. of India, was established in the year 1990. Since its inception NIC, Hooghly has been busy in playing a catalytic role to cultivate IT culture in the government departments of the district. As the office is situated in the Collectores premises, it has become integral part of the District Administration. NIC, Hooghly plays a dual role in implementing State and Central Government IT projects and helping the local administration in exercising day to day IT activities in the district.
The National Institute of Immunology (NII) is committed to advanced research addressing the basic mechanisms involved in body's defence to identify modalities for manipulation of the immune system to provide protection against diseases and understand mechanisms that can be used to target disease processes for intervention. The institute’s research thrust areas under immunology and related disciplines cluster in four main themes, namely, infection and immunity, molecular design, gene regulation and reproduction and development, where cutting edge research in modern biology is being carried out.
Applications are invited for the position of Junior Research Fellow (Project) for the following time-bound sponsored project as per the details given below.
Founded in the year 2007, Om Group of Colleges is both large in size and reputation. Placement and employability are key focus training process. At Om Group of Colleges, perspective on learning is different. As an institute we recognize that professional education is about thinking and doing. An important element of our learning is how you learn to drive yourself and deliver. All these efforts are accomplished with the help of a highly qualified and dedicated team of faculty where there is a judicious blend of academic and industry background. We are confident that young men and women will do their best through diligent and innovative work to become next generation professionals.
Vivek Group of colleges has established the college of pharmacy in the year 2005 to impart high quality education in the field of pharmacy. The College (Code-210) is running D.Pharm, B.Pharm & M.Pharm in Pharmaceutics and Pharmacology specializations. The college is affiliated to Dr. APJ AKTU Lucknow and is approved by Pharmacy Council of India and AICTE New Delhi. The College provides a stimulating and productive environment for Pharmaceutical education and research. The campus is equipped with modern labs, classrooms, seminar hall, library, student centre for co-curricular activities, computer lab, academic and administrative blocks and other amenities for exclusive and widespread provision for indoor and outdoor games. All the classrooms are spaciously designed and are well furnished with necessary technical teaching aids like LCD Projector, Laptop and power supply.
Roche Pharmaceuticals, India, has been disseminating scientific knowledge pertaining to innovative medicines to the medical fraternity. We have products in therapeutic areas such as Oncology, Virology, Nephrology, Transplantation, Anemia and Rheumatoid Arthritis. In recognition of its contributions in Oncology, Roche India has been awarded the Best Oncology Company of the Year, by Frost & Sullivan at the India Healthcare Excellence Awards for the years 2011, 2012 and 2014.
Established in the early 90's, this organization has emerged as an integrated pharmaceutical company offering products to the global market. Headquartered at Delhi NCR, India and plant in North India, the Company develops, manufactures and markets a wide range of quality products in diverse area of treatment.Over the years, the organization has positioned itself as a significant player in the Russian and CIS markets and has expanded its foothold in the US, Europe, India and other markets. The key competitive advantage lies in having the Research & Development centre together with the world class manufacturing facility that has enabled it to provide end-to-end solutions from product development to marketing. The manufacturing facilities are approved by many regulatory bodies including EUGMP and WHOGMP thereby allowing the company to reach International markets.
Post : Research Scientist – Formulation Development
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Shire traces its history back to 1986, when a small team of entrepreneurs sought out a solution to address on a number of unmet medical needs. Within its first two years of operation, the company had launched a range of supplemental calcium products for patients seeking to treat or prevent osteoporosis. Soon thereafter, innovative drug development programs were under way on behalf of patients facing such challenging conditions as Alzheimer's disease and end-stage renal failure.
A memorable advance was made in the development of local self Govt. in Baroda State in the year 1892, when Sudharai Nibandh Municipal Act was passed by his highness Late Shri Maharaja Sayajirao Gaekwad. It recoginsed for the first time the elective principal in Baroda Municipal Govt. Under this Act, the city was devided into 22 wards, each to elect one member to the Municipal Baroda. Besides the large number of elected members, there were eight ex-officio members, The Sudharai Kamdar, The municipal commissioner being the ex-officio president of the municipality. The whole cost of municipal administration was borne by the Baroda State Govt.
Govt. of Himachal Pradesh took up initiative in early seventies to set up a CSIR lab to make prudential use of the natural resources of the region. After several levels of discussions a formal request was made by then Chief Minister of HP to Vice President, CSIR in 1982 for initiating the matter, and giving final shape to the proposal. The dream of HP government finally came true in 1983 when the foundation stone of this National lab was laid as CSIR Complex Palampur by Prof. Nurul Hasan, former Vice President of CSIR, with then Chief Minister of HP chairing the function.
The Dr. Reddy's Institute of Life Sciences was conceived in the context of globalization, to foster research competence in India and to bridge the divide between academic research and the pharmaceutical & biotechnology industries. The institute was incorporated as a non-profit entity under Section 25 of the Indian companies act, facilitating operational autonomy. Construction of the DRILS building comprising 44 labs and an administrative block and spanning ~130,000 sq.ft. in area, began in 2004 and was completed in January 2007.